FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Emilia Barcia

Research Profile

Chemicals & Drugs

Procedures

Concepts & Ideas

Objects

Microspheres

Disorders

Neoplasms

Co-author Network

Publications

TOP 3
M Fernández; Ana Fernández-Carballido; L Garcia; Emilia Barcia; Karla Slowing; Sofía Negro
Controlled release of rasagiline mesylate promotes neuroprotection in a rotenone-induced advanced model of Parkinson's disease.
Marcos Fernández; Ana Fernández-Carballido; Sofía Negro; Karla Slowing; Emilia Barcia
An effective novel delivery strategy of rasagiline for Parkinson's disease.
Emilia Barcia; Ana Fernández-Carballido; A Salama; Sofía Negro
Protective effects of clioquinol on human neuronal-like cells: a new formulation of clioquinol-loaded PLGA microspheres for Alzheimer's disease.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Emilia Barcia (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: M Fernández; Ana Fernández-Carballido; L Garcia; Emilia Barcia; Karla Slowing; Sofía Negro
Controlled release of rasagiline mesylate promotes neuroprotection in a rotenone-induced advanced model of Parkinson's disease.
International journal of pharmaceutics 2012;438(1-2):266-78.
2011: Marcos Fernández; Ana Fernández-Carballido; Sofía Negro; Karla Slowing; Emilia Barcia
An effective novel delivery strategy of rasagiline for Parkinson's disease.
International journal of pharmaceutics 2011;419(1-2):271-80.
2011: Emilia Barcia; Ana Fernández-Carballido; A Salama; Sofía Negro
Protective effects of clioquinol on human neuronal-like cells: a new formulation of clioquinol-loaded PLGA microspheres for Alzheimer's disease.
Journal of drug targeting 2011;19(8):637-46.
2011: Maha Cheddadi; Enrique López-Cabarcos; Karla Slowing; Emilia Barcia; Ana Fernández-Carballido
Cytotoxicity and biocompatibility evaluation of a poly(magnesium acrylate) hydrogel synthesized for drug delivery.
International journal of pharmaceutics 2011;413(1-2):126-33.
2010: C Montejo; Emilia Barcia; Sofía Negro; Ana Fernández-Carballido
Effective antiproliferative effect of meloxicam on prostate cancer cells: development of a new controlled release system.
International journal of pharmaceutics 2010;387(1-2):223-9.
2009: Emilia Barcia; Rocío Herrero-Vanrell; Ana Díez; Consuelo Alvarez-Santiago; Isabel López; Margarita Calonge
Downregulation of endotoxin-induced uveitis by intravitreal injection of polylactic-glycolic acid (PLGA) microspheres loaded with dexamethasone.
Experimental eye research 2009;89(2):238-45.
2009: Marcos Fernández; Emilia Barcia; Sofía Negro
Development and validation of a reverse phase liquid chromatography method for the quantification of rasagiline mesylate in biodegradable PLGA microspheres.
Journal of pharmaceutical and biomedical analysis 2009;49(5):1185-91.
2008: Ana Fernández-Carballido; Pilar Pastoriza; Emilia Barcia; C Montejo; Sofía Negro
PLGA/PEG-derivative polymeric matrix for drug delivery system applications: Characterization and cell viability studies.
International journal of pharmaceutics 2008;352(1-2):50-7.
2007: Sofía Negro; A Salama; Yolanda Sánchez; María Luz Azuara; Emilia Barcia
Compatibility and stability of tramadol and dexamethasone in solution and its use in terminally ill patients.
Journal of clinical pharmacy and therapeutics 2007;32(5):441-4.
2007: Emilia Barcia; Alicia Martín; María Luz Azuara; Yolanda Sánchez; Sofía Negro
Tramadol and hyoscine N-butyl bromide combined in infusion solutions: compatibility and stability.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2007;15(1):57-62.
2006: Sofía Negro; Rodrigo Reyes; María Luz Azuara; Yolanda Sánchez; Emilia Barcia
Morphine, haloperidol and hyoscine N-butyl bromide combined in s.c. infusion solutions: compatibility and stability. Evaluation in terminal oncology patients.
International journal of pharmaceutics 2006;307(2):278-84.
2006: Sofía Negro; Ana Lucía Rendon; María Luz Azuara; Yolanda Sánchez; Ana Fernández-Carballido; Emilia Barcia
Compatibiliity and stability of furosemide and dexamethasone combined in infusion solutions.
Arzneimittel-Forschung 2006;56(10):714-20.
2005: Patricia Puebla; Pilar Pastoriza; Emilia Barcia; Ana Fernández-Carballido
PEG-derivative effectively modifies the characteristics of indomethacin-PLGA microspheres destined to intra-articular administration.
Journal of microencapsulation 2005;22(7):793-808.
2005: Sofía Negro; Alicia Martín; María Luz Azuara; Yolanda Sánchez; Emilia Barcia
Stability of tramadol and haloperidol for continuous subcutaneous infusion at home.
Journal of pain and symptom management 2005;30(2):192-9.
2005: Emilia Barcia; Sofía Negro
Interactions of anti-infectives: a review.
Chemotherapy 2005;51(4):197-9.
2005: Emilia Barcia; Rodrigo Reyes; María Luz Azuara; Yolanda Sánchez; Sofía Negro
Stability and compatibility of binary mixtures of morphine hydrochloride with hyoscine-n-butyl bromide.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2005;13(4):239-45.
2005: Emilia Barcia; Alicia Martin; María Luz Azuara; Sofía Negro
Influence of medium and temperature on the hydrolysis kinetics of propacetamol hydrochloride: determination using derivative spectrophotometry.
Chemical & pharmaceutical bulletin 2005;53(3):277-80.
2003: Emilia Barcia; Rodrigo Reyes; María Luz Azuara; Yolanda Sánchez; Sofía Negro
Compatibility of haloperidol and hyoscine-N-butyl bromide in mixtures for subcutaneous infusion to cancer patients in palliative care.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2003;11(2):107-13.
2002: Sofía Negro; María Luz Azuara; Yolanda Sánchez; Rodrigo Reyes; Emilia Barcia
Physical compatibility and in vivo evaluation of drug mixtures for subcutaneous infusion to cancer patients in palliative care.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2002;10(1):65-70.
2001: Sofía Negro; Rocío Herrero-Vanrell; Emilia Barcia; S Villegas
Comparative study of the dissolution profiles of a commercial theophylline product after storage.
Archives of pharmacal research 2001;24(6):568-71.